GlycoMimetics (GLYC) Stock Chart & Stock Price History Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics Stock Price Performance The GlycoMimetics (GLYC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 100.00%, with a year-to-date return of -100.00%. In the past month, the stock has decreased 100.00%, reflecting recent market activity. As of the latest close, GlycoMimetics traded at $0.16 with a market cap of $10.00 million and volume of 1.05 million shares. Five years ago, the stock traded at a split-adjusted price of $380.00, representing a 100.00% decrease over that period. At the time, it had a market cap of $163.87 million and a volume of 4,718 shares. Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-100.00%1 Month Performance-100.00%3 Month Performance-100.00%Year-To-Date Performance-100.00%1 Year Performance-100.00%5 Year Performance-100.00% GLYC Stock Chart for Sunday, July, 6, 2025 GLYC Chart by TradingView GlycoMimetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/03/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/02/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million07/01/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/30/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/27/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/26/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/25/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/24/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/23/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/19/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/18/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/17/2025$0.16$0.16$0.17$0.151.05 million shs$10.00 million06/16/2025$0.16$0.16-1.27%$0.17$0.151.05 million shs$10.00 million06/13/2025$16.60$15.70-5.42%$17.00$15.3010,497 shs$10.13 million06/12/2025$16.60$16.60$17.25$15.3518,535 shs$10.71 million06/11/2025$17.04$16.60-2.58%$17.91$16.0017,763 shs$10.71 million06/10/2025$17.66$17.04-3.51%$17.50$15.1517,794 shs$11.00 million06/09/2025$19.38$17.66-8.88%$18.40$17.2226,938 shs$11.40 million06/06/2025$19.86$19.38-2.42%$21.18$17.74584,282 shs$12.51 million06/05/2025$21.00$19.86-5.43%$20.79$19.86247,246 shs$12.82 million Related Companies Iterum Therapeutics Stock Price Chart Pluri Stock Price Chart Shattuck Labs Stock Price Chart ABVC BioPharma Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Akari Therapeutics Stock Price Chart Barinthus Biotherapeutics Stock Price Chart Acrivon Therapeutics Stock Price Chart Karyopharm Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Receive GLYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLYC) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLYC Stock Alerts